Executive Vice President and Chief Operating Officer and Managing Director, Europe and International · Jazz Pharmaceuticals plc (JAZZ)

Chris Tovey

FY2021 is the first fiscal year CompBrief holds for Chris Tovey as a named executive officer of Jazz Pharmaceuticals; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$4,168,001

Salary $366,576Stock awards $3,287,387Bonus $297,567

4th of 6 named executive officers at Jazz Pharmaceuticals by FY2021 total.

6 named officers on file for Jazz Pharmaceuticals, FY2021

Chris Tovey’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • JAZZ’s disclosed peer group of 13 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Jazz Pharmaceuticals’s whole pay program stands against its peers

  • Jazz Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on JAZZ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 13, 2022 (DEF 14A).

Free

Get Chris Tovey’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Chris Tovey compensation by year

Jazz Pharmaceuticals Summary Compensation Table · the one fiscal year held
In US dollars, as Jazz Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$366,576
Bonus$297,567
Stock awards$3,287,387
Option awards$0
Non-equity incentive$211,782
Pension and deferred compensation$0
All other$4,689
Total$4,168,001

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Jazz Pharmaceuticals plc DEF 14A filed June 13, 2022, accession 0001193125-22-172177, and prior-year filings.

How this page was built: the Jazz Pharmaceuticals plc filed document, accession 0001193125-22-172177. Every figure is read from that document and cited to the page and table it appears in. Filed June 13, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU9,091$1,158,193—
RSU9,090$1,158,066—
Option8,063—$0.02

Per the Outstanding Equity Awards at Fiscal Year-End table in Jazz Pharmaceuticals plc's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Jazz Pharmaceuticals’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Bruce CozaddChairperson and CEO$15,679,311
Daniel Swisher Jr.President$5,403,892
Renée GaláExecutive Vice President and CFO$4,605,224
Chris Tovey · this pageExecutive Vice President and Chief Operating Officer and Managing Director, Europe and International$4,168,001
Robert IannoneExecutive Vice President, Global Head of Research and Development$4,001,336
Kim SablichExecutive Vice President and General Manager, US$3,947,509

The full Jazz Pharmaceuticals compensation record

free company brief

This page is one person within Jazz Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Jazz Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Jazz Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Chris Tovey's compensation dossier · One-time report. No refunds.